Change in list and net drug prices select manufacturers U.S. 2017-2022
In 2022, the average U.S. net price of product portfolios of large pharmaceutical manufacturers decreased by 1.5 percent from the previous year. In the same year, the average increase of the U.S. list price compared to the previous year was four percent. This statistic illusrates the change in U.S. list and net pharmaceutical product prices from 2017 to 2022.
